ARTICLE | Clinical News
StarGen: Interim Phase I/IIa data
December 10, 2012 8:00 AM UTC
Oxford BioMedica and partner Sanofi reported interim data from 8 patients with Stargardt's disease in the first cohort of an open-label, dose-escalation, international Phase I/IIa trial showing that S...